相似文献
1
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth.
Antimicrob Agents Chemother. 2002 Apr;46(4):1153-5. doi: 10.1128/AAC.46.4.1153-1155.2002.
2
Nonfilamentous C. albicans mutants are avirulent.
Cell. 1997 Sep 5;90(5):939-49. doi: 10.1016/s0092-8674(00)80358-x.
3
Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection.
Infect Immun. 2002 Feb;70(2):921-7. doi: 10.1128/IAI.70.2.921-927.2002.
4
Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium.
J Med Microbiol. 2003 Aug;52(Pt 8):623-632. doi: 10.1099/jmm.0.05125-0.
5
Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
Mycol Res. 2009 Mar;113(Pt 3):388-90. doi: 10.1016/j.mycres.2008.11.016. Epub 2008 Dec 16.
6
Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
Int J Antimicrob Agents. 2015 Jun;45(6):617-21. doi: 10.1016/j.ijantimicag.2015.01.017. Epub 2015 Mar 6.
7
EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells.
J Bacteriol. 2000 Mar;182(6):1580-91. doi: 10.1128/JB.182.6.1580-1591.2000.
8
In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion.
Microbiology (Reading). 2002 Feb;148(Pt 2):497-506. doi: 10.1099/00221287-148-2-497.
9
Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.
Eukaryot Cell. 2013 Jan;12(1):37-49. doi: 10.1128/EC.00236-12. Epub 2012 Nov 2.
10
Chlamydospore formation in Candida albicans requires the Efg1p morphogenetic regulator.
Infect Immun. 1999 Oct;67(10):5514-7. doi: 10.1128/IAI.67.10.5514-5517.1999.
引用本文的文献
1
Impact on the Progression, Morphology, and Cellular Integrity of Biofilm Formation on the Surfaces of Implants; Current Knowledge and Future Perspectives.
Int J Mol Cell Med. 2025 Jul 1;14(2):620-636. doi: 10.22088/IJMCM.BUMS.14.2.620. eCollection 2025.
2
Host albumin redirects Candida albicans metabolism to engage an alternative pathogenicity pathway.
Nat Commun. 2025 Jul 12;16(1):6447. doi: 10.1038/s41467-025-61701-5.
3
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.
J Fungi (Basel). 2024 May 27;10(6):382. doi: 10.3390/jof10060382.
4
Molecular Determinants Involved in Candida albicans Biofilm Formation and Regulation.
Mol Biotechnol. 2024 Jul;66(7):1640-1659. doi: 10.1007/s12033-023-00796-x. Epub 2023 Jul 6.
5
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies.
Curr Microbiol. 2022 Mar 14;79(5):127. doi: 10.1007/s00284-022-02824-6.
6
Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans.
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01584-20.
7
Priming with FLO8-deficient Candida albicans induces Th1-biased protective immunity against lethal polymicrobial sepsis.
Cell Mol Immunol. 2021 Aug;18(8):2010-2023. doi: 10.1038/s41423-020-00576-6. Epub 2020 Nov 5.
8
Divergent Approaches to Virulence in and : Two Sides of the Same Coin.
Int J Mol Sci. 2019 May 11;20(9):2345. doi: 10.3390/ijms20092345.
9
Inactivation of genes TEC1 and EFG1 in influences extracellular matrix composition and biofilm morphology.
J Oral Microbiol. 2017 Oct 17;9(1):1385372. doi: 10.1080/20002297.2017.1385372. eCollection 2017.
10
Zebrafish Egg Infection Model for Studying Candida albicans Adhesion Factors.
PLoS One. 2015 Nov 16;10(11):e0143048. doi: 10.1371/journal.pone.0143048. eCollection 2015.
本文引用的文献
1
Signal transduction cascades regulating fungal development and virulence.
Microbiol Mol Biol Rev. 2000 Dec;64(4):746-85. doi: 10.1128/MMBR.64.4.746-785.2000.
2
Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture.
Infect Immun. 1999 Jul;67(7):3649-52. doi: 10.1128/IAI.67.7.3649-3652.1999.
3
Nonfilamentous C. albicans mutants are avirulent.
Cell. 1997 Sep 5;90(5):939-49. doi: 10.1016/s0092-8674(00)80358-x.
4
Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi.
EMBO J. 1997 Apr 15;16(8):1982-91. doi: 10.1093/emboj/16.8.1982.
5
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
Clin Infect Dis. 1996 May;22 Suppl 2:S89-94. doi: 10.1093/clinids/22.supplement_2.s89.
6
Isogenic strain construction and gene mapping in Candida albicans.
Genetics. 1993 Jul;134(3):717-28. doi: 10.1093/genetics/134.3.717.
7
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.
Science. 1994 Dec 9;266(5191):1723-6. doi: 10.1126/science.7992058.
8
Adherence of candida species to intravenous catheters.
J Infect Dis. 1983 Mar;147(3):594. doi: 10.1093/infdis/147.3.594.
9
Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory.
J Clin Microbiol. 1990 Jan;28(1):76-82. doi: 10.1128/jcm.28.1.76-82.1990.
Zotero 插件